- Report
- April 2024
- 196 Pages
Global
From €4816EUR$4,950USD£4,126GBP
- Report
- March 2020
- 236 Pages
Global
From €3503EUR$3,600USD£3,001GBP
- Report
- March 2020
- 91 Pages
Asia Pacific
From €1459EUR$1,500USD£1,250GBP
- Report
- March 2020
- 90 Pages
Middle East, Africa
From €1459EUR$1,500USD£1,250GBP
- Report
- March 2020
- 90 Pages
Europe
From €1459EUR$1,500USD£1,250GBP
- Report
- March 2020
- 78 Pages
North America
From €1459EUR$1,500USD£1,250GBP
- Report
- March 2020
- 207 Pages
Global
From €5225EUR$5,370USD£4,476GBP
The Intrapulmonary Percussive Ventilator (IPV) is a type of respiratory device used to treat patients with respiratory diseases. It is a non-invasive, mechanical ventilation system that uses a combination of positive pressure and percussive air pulses to help clear airways and improve lung function. IPV is used to treat a variety of respiratory conditions, including asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and bronchiectasis. It is also used to treat patients with acute respiratory distress syndrome (ARDS).
IPV is a relatively new technology, and is becoming increasingly popular due to its non-invasive nature and its ability to improve lung function. It is also cost-effective and easy to use.
Some companies in the Intrapulmonary Percussive Ventilator market include Philips Respironics, Vyaire Medical, ResMed, and Fisher & Paykel Healthcare. Show Less Read more